T1	Outcomes 0 55	Cardiovascular safety and gastrointestinal tolerability
T2	Outcomes 167 227	cardiovascular (CV) and other safety and efficacy parameters
T3	Outcomes 643 679	Other safety and efficacy parameters
T4	Outcomes 866 902	thrombotic CV risk hazard ratio (HR)
T5	Outcomes 1025 1105	cumulative gastrointestinal (GI)/liver adverse events (AEs) discontinuation rate
T6	Outcomes 1306 1360	maximum average change in systolic blood pressure (BP)
T7	Outcomes 1553 1561	efficacy
T8	Outcomes 1650 1678	risk of thrombotic CV events
T9	Outcomes 1775 1799	risk of renovascular AEs
T10	Outcomes 1823 1853	GI/liver tolerability profile.
